Alimak Group AB (0R8W)
London Exchange · UK · prices in SEK · close of 22 Oct 2026
Key indicators
| Last close | SEK 122.00 |
|---|---|
| 52-week range | 104.00 – 150.40 |
| Return, 1 month / 3 months | −1.0% / −3.3% |
| Return, 1 year / 3 years | −16.4% / +113.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 27.0% |
| Worst drawdown (1 year) | -28.6% |
| Average daily value traded | 1.75M SEK |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alimak Group is a Swedish manufacturer of vertical access equipment, including construction hoists, industrial elevators and related service offerings. Its machines are used on building sites, in infrastructure projects and for maintenance work in factories and other industrial settings. The company serves contractors, industrial operators and building owners, and it also provides service and support for its installed equipment. Alimak Group is based in Sweden and operates internationally.
On this site Alimak Group AB appears as a stock on the London Exchange (UK), code 0R8W, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alimak Group AB (0R8W) trades on the London Exchange in UK. It last closed at SEK 122.00 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,848 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.4% and over the last three months it fell 3.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.1% | ||
| From 52-week high | -18.8% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.3% | ||
| 6-month return | 7.9% | ||
| 12-month return, skipping the last month | -15.6% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.6% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.75M SEK | ||
| Zero-volume days | 15.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −1.0% |
| 3 months | −3.3% |
| 6 months | +7.9% |
| 1 year | −16.4% |
| 3 years | +113.9% |
| 5 years | +53.3% |
Signals
| 50-day / 200-day average | 123.94 / 119.52 |
|---|---|
| Golden / death cross (60 days) | Golden, 39 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.13 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | SEK 3.3000 |
| 2 May 2025 | SEK 3.0000 |
| 30 Apr 2024 | SEK 2.5000 |
| 5 May 2023 | SEK 1.8200 |
| 6 May 2022 | SEK 3.3000 |
| 7 May 2021 | SEK 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.